Sphinx Pharmaceuticals Corp. of Durham, N.C., said Tuesdaythat it has begun a Phase II clinical trial of its lead product,Kynac ointment, for treating the signs and symptoms ofpsoriasis.

(c) 1997 American Health Consultants. All rights reserved.

No Comments